GSDMD and diabetic kidney disease: Notably, it inhibited the activation of the NLRP3 inflammasome, a key driver of inflammation in DKD, thereby downregulating pyroptosis-related proteins such as Caspase-1 and Gasdermin D (GSDMD), and decreasing circulating IL-1β and IL-18 levels.